What happens if I choose no treatment for Kidney Cancer

Understanding "No Treatment" for Kidney Cancer

This is an important question, and the answer depends significantly on your specific situation—particularly your cancer stage, tumor size, and overall health. Let me walk you through what the medical evidence shows.

What "No Treatment" Actually Means

When we talk about "no treatment," we're usually referring to one of two approaches:

1. Active Surveillance - Regular monitoring with imaging and blood work, but no immediate surgery or systemic therapy
2. True "watchful waiting" - Minimal or no follow-up (this is generally NOT recommended)

These are very different paths with different outcomes.

Active Surveillance: A Legitimate Medical Option

According to the NCCN Guidelines for Kidney Cancer (Version 1.2026), active surveillance is actually a recommended option for certain patients, particularly those with:

• Small tumors (less than 3 cm)
• Stage T1a disease (tumors ≤4 cm with a predominantly cystic component)
• Significant competing health risks (other serious medical conditions where surgery poses greater danger than the cancer itself)
• Limited life expectancy from other causes

What Active Surveillance Involves:

• Serial imaging (CT or MRI scans) at regular intervals to monitor tumor size and growth rate
• Blood work to assess kidney function and overall health
• Chest imaging periodically, especially for higher-stage disease
• Timely intervention if the tumor shows concerning changes (rapid growth, infiltrative pattern, increasing size)

Key finding from NCCN Guidelines: Studies show that small renal masses have high rates of benign tumors and low metastatic potential (low likelihood of spreading), which is why monitoring can be safe for selected patients.

What Happens Without Any Monitoring?

If you choose no treatment AND no surveillance, the risks include:

• Delayed diagnosis of progression - Your cancer could grow or spread without your knowledge
• Loss of treatment windows - Some cancers become harder to treat once they've advanced
• Potential for metastatic disease - The cancer could spread to distant organs (lungs, bones, brain) before you have symptoms
• Symptom development - Advanced kidney cancer can cause pain, blood in urine, weight loss, and fatigue

Stage-Specific Considerations

Your stage matters enormously:

Stage I (T1a - small tumors ≤4 cm):

• Active surveillance is a reasonable option
• Many of these tumors grow very slowly or not at all
• NCCN Guidelines note that competing health risks may make surveillance preferable to surgery

Stage I (T1b - tumors 4-7 cm):

• Active surveillance is an option for select patients
• More careful monitoring is typically needed
• Risk of progression is higher than T1a

Stage II, III, or IV (larger or advanced disease):

• Active surveillance alone is generally NOT recommended
• These typically require surgery, systemic therapy (immunotherapy or targeted drugs), or other interventions
• Without treatment, progression is more likely

The Medical Framework: How Doctors Think About This

According to NCCN Guidelines, oncologists consider:

1. Tumor characteristics - Size, growth rate, imaging appearance
2. Your performance status - Your overall health and ability to tolerate treatment
3. Competing risks - Other health conditions that might make treatment more dangerous than the cancer
4. Life expectancy - How long you're likely to live from all causes
5. Patient preference - Your values and what matters to you

Questions to Ask Your Kidney Cancer Team

If you're considering no active treatment, these questions are essential:

1. What is my specific stage and tumor size? (This determines risk level)
2. Based on my tumor characteristics, what is the risk of progression if I don't treat it?
3. Am I a candidate for active surveillance, and what would that monitoring schedule look like?
4. What symptoms should I watch for that would indicate I need treatment?
5. If I choose surveillance now, can I still pursue treatment later if the tumor grows? (Usually yes, but timing matters)
6. What are my treatment options if the tumor does progress?

Important Boundaries

This information is educational. Your specific situation requires your oncologist's evaluation. Factors like your exact tumor stage, grade, histology (cell type), your age, kidney function, and other health conditions all influence whether active surveillance is safe for you versus whether you need immediate treatment.

Some patients with small, slow-growing tumors do very well with active surveillance. Others with more aggressive cancers need prompt treatment. Your oncologist will determine the most appropriate approach for YOUR case based on your complete clinical picture.

According to the NCCN Guidelines, the key principle is: "No single follow-up plan is appropriate for all patients. Follow-up should be individualized based on patient requirements."

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.